(Q47716717)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23971720%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

title

Berberis aristata/Silybum marianum fixed combination on lipid profile and insulin secretion in dyslipidemic patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23971720%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Berberis aristata

1 reference

Silybum marianum

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23971720%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Pamela Maffioli

series ordinal

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23971720%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

Aldo Bonaventura

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23971720%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

4

Davide Romano

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23971720%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

5

Angela D'Angelo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23971720%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

6

Elena Fogari

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23971720%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

3

Lucio Bianchi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23971720%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

language of work or name

English

0 references

publication date

24 August 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23971720%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Biological Therapy

8 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23971720%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23971720%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23971720%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

page(s)

1495-1506

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23971720%20AND%20SRC:MED&resulttype=core&format=json

High density lipoprotein and cardiovascular diseases.

8 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.832751

High-density lipoprotein levels and risk of cardiovascular events: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.832751

Effectiveness of Ezetimibe in Reducing the Estimated Risk for Fatal Cardiovascular Events in Hypercholesterolaemic Patients with Inadequate Lipid Control While on Statin Monotherapy as Measured by the SCORE Model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.832751

Tolerability and safety of commonly used dietary supplements and nutraceuticals with lipid-lowering effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.832751

Effects of n-3 PUFAs on postprandial variation of metalloproteinases, and inflammatory and insulin resistance parameters in dyslipidemic patients: evaluation with euglycemic clamp and oral fat load.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.832751

Berberine on metabolic and cardiovascular risk factors: an analysis from preclinical evidences to clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.832751

Phyto-chemical and pharmacological applications of Berberis aristata

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.832751

Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.832751

Berberine inhibits adipogenesis in high-fat diet-induced obesity mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.832751

Bioavailability study of berberine and the enhancing effects of TPGS on intestinal absorption in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.832751

The involvement of P-glycoprotein in berberine absorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.832751

Effect of ion-pair formation with bile salts on the in vitro cellular transport of berberine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.832751

Herbal modulation of P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.832751

Pilot study on the additive effects of berberine and oral type 2 diabetes agents for patients with suboptimal glycemic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.832751

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.832751

THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUM

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.832751

The effects of berberine on blood lipids: a systemic review and meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.832751

Inhibition of lipid synthesis through activation of AMP kinase: an additional mechanism for the hypolipidemic effects of berberine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.832751

Effects of polyphenolic fraction of silymarin on lipoprotein profile in rats fed cholesterol-rich diets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.832751

Effect of silymarin and its polyphenolic fraction on cholesterol absorption in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.832751

Berberine-stimulated glucose uptake in L6 myotubes involves both AMPK and p38 MAPK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.832751

The efficacy of Silybum marianum (L.) Gaertn. (silymarin) in the treatment of type II diabetes: a randomized, double-blind, placebo-controlled, clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2013.832751

10.1517/14712598.2013.832751

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23971720%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

1 reference